Down SYNDROME (Acute REgression) treatment
APC-100: An Oral Administration Revolutionizing Disease Treatment! Safe and the First-Ever Curative Solution!
Product like ours, “Neuro Regeneration Therapy”, has the promise to become the first Down Syndrome therapy to restore function rather than just treating symptoms.
Who we are
- Founded in 2022
- Chicago-based Company
- Parent company: Progenicyte Japan, oversees several innovative products that are in line with the mission of Progenicyte Therapeutics, Inc.
- We are aiming to develop first orally administered treatment for Down Syndrome through stem cell regeneration.
Experience the Difference
- We are poised to introduce a groundbreaking small molecular weight compound to the clinical setting, capable of significantly augmenting the population of endogenous stem cells within our bodies.
- We are the first Down Syndrome therapy to restore functions rather than just treating symptoms.
Leadership Team
Keiji Asada, Co-Founder, Chief Executive Officer
Kiminobu Sugaya, Co-Founder, Chief Scientific Officer
Kiminobu Sugaya, Co-Founder, Chief Scientific Officer
With over two decades of expertise in Life Sciences business development and sales, Keiji stands as a seasoned professional adept at fostering partnerships between U.S. and Japanese companies. As the visionary behind Amenichi Consulting, LLC, a highly accomplished FDA regulatory consulting firm specializing in facilitating regulatory fili
With over two decades of expertise in Life Sciences business development and sales, Keiji stands as a seasoned professional adept at fostering partnerships between U.S. and Japanese companies. As the visionary behind Amenichi Consulting, LLC, a highly accomplished FDA regulatory consulting firm specializing in facilitating regulatory filings for pharmaceutical and biotechnology companies, Keiji has demonstrated his deep knowledge and proficiency in navigating the complexities of FDA regulations. Moreover, his extensive background spans scientific research, drug development, and venture investing, solidifying his well-rounded understanding of the intricacies involved in the life sciences industry.
Kiminobu Sugaya, Co-Founder, Chief Scientific Officer
Kiminobu Sugaya, Co-Founder, Chief Scientific Officer
Kiminobu Sugaya, Co-Founder, Chief Scientific Officer
With an illustrious career spanning over three decades, Dr. Sugaya is a distinguished authority in the field of Alzheimer's research. As the esteemed professor and head of the Neuroscience department at the University of Central Florida, he plays a pivotal role in advancing scientific understanding and driving innovation in the realm of n
With an illustrious career spanning over three decades, Dr. Sugaya is a distinguished authority in the field of Alzheimer's research. As the esteemed professor and head of the Neuroscience department at the University of Central Florida, he plays a pivotal role in advancing scientific understanding and driving innovation in the realm of neurobiology. Furthermore, Dr. Sugaya's influence extends to his position as the chair and CEO of Progenicyte Japan, Inc., the parent company of Progenicyte Therapeutics, Inc. Under his visionary leadership, these organizations are at the forefront of pioneering stem cell therapies for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and ALS. Driven by his passion and commitment, he has authored over 15 influential publications focused on stem cell research, further solidifying his expertise and dedication to improving the lives of those affected by these debilitating conditions.
Christian Friese, Advisor
Kiminobu Sugaya, Co-Founder, Chief Scientific Officer
Christian Friese, Advisor
Christian is a highly accomplished biopharma marketing expert with a strong track record of success. With a keen focus on new product planning strategy and the commercialization of innovative pharmaceutical products, Christian has consistently delivered exceptional results. He has honed his expertise through his tenure at esteemed organiz
Christian is a highly accomplished biopharma marketing expert with a strong track record of success. With a keen focus on new product planning strategy and the commercialization of innovative pharmaceutical products, Christian has consistently delivered exceptional results. He has honed his expertise through his tenure at esteemed organizations such as Schering AG, IDEC, Biogen, Medivation, and AstraZeneca, where he has played a pivotal role in driving strategic marketing initiatives on a global scale. Christian's wealth of experience and industry knowledge make him an invaluable asset in navigating the complex landscape of biopharmaceutical marketing.